Here are some of the stocks making notable moves in Wednesday’s premarket action: Netflix shares are down more than 5% after the streaming giant
Latest News
Stock market today: Dow Jones, S&P 500 futures recover as focus turns to Trump’s Davos address—Johnson & Johnson, Intel, GameStop in focus
U.S. stock futures rose on Wednesday following Tuesday’s sharp sell-off. Futures of major benchmark indices were higher. On Tuesday, the S&P 500 index recorded
Stock Market Today: Dow, S&P 500 and Nasdaq eye rally after sharp sell-off as government bonds recover some poise; gold hits new record above $4,800; Trump to give Davos speech.
Follow all the latest U.S. market action for Wednesday here to see if stocks can rebound after geopolitical tensions and fiscal concerns hit sentiment
Stock Market Today, Jan. 21: Trump travels to Switzerland amid Greenland exchange
Happy Wednesday. This is TheStreet’s Stock Market Today for Jan. 21, 2026. You can follow the latest updates on the market here in our
Stock Market Today: Dow Futures Edge Up; Gold Extends Gains
Follow along for live updates on the Dow, S&P 500, Nasdaq and other markets.
Stock market crash: Nifty 50 slips below 25,000 — is it a warning sign for long-term investors?
DMA near 25,150, which Santosh Meena of Swastika said is widely regarded as the dividing line between a long-term bull and bear market. He
IFN: Indian Stock Market Correction Set To Continue As Headwinds Remain In 2026
Despite India’s robust economic growth and strong consumer sentiment, IFN’s portfolio trades at a PE above 30. Read why I continue to rate IFN
Profiting From Selling Put Options in Any Market
Learn how selling put options can create income and offer discounted stock purchases. Use our guide to master this strategy in various market climates.
Why Sigma Lithium Stock Soared While the Market Dived Today
Reflecting the highly reactive element within its name, Sigma Lithium ( SGML +9.78%) has been a volatile stock over the past few trading days.
Stock Market Today, Jan. 20: ImmunityBio Soars Again After FDA Outlines Resubmission Path for ANKTIVA in Bladder Cancer
On Jan. 20, 2026, investors weigh ImmunityBio’s sharp rally on new FDA feedback around its bladder cancer plans.